Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04136756
Title NKTR-255 in Relapsed/Refractory Multiple Myeloma and Non Hodgkin Lymphoma and Combined With Daratumumab for Multiple Myeloma
Recruitment Enrolling by invitation
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nektar Therapeutics
Indications

non-Hodgkin lymphoma

multiple myeloma

Therapies

NKTR-255

Daratumumab + NKTR-255

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Western Regional Medical Center - CTCA Goodyear Arizona 85338 United States Details
City of Hope Duarte California 91010 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
New York Medical College Valhalla New York 10595 United States Details
Duke University Health System Durham North Carolina 27705 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field